Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Pathologie-Biologie
|
December 1, 1991
[Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers]
H Etesse-Carsenti, R Garraffo, E Bernard, et al.
European Journal of Ophthalmology
|
January 19, 2008
Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteers
F Chiambaretta, R Garraffo, P P Elena, et al.
HIV Clinical Trials
|
December 26, 2002
Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir
S Chaillou, J Durant, R Garraffo, et al.
Alimentary Pharmacology & Therapeutics
|
June 15, 2018
Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort
A Provoost, M Dramé, L Cotte, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 31, 2005
Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance
Bernard Masquelier, Edwige Pereira, Gilles Peytavin, et al.
Fundamental & Clinical Pharmacology
|
February 24, 2001
Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients
F X Caroli-Bosc, A Iliadis, L Salmon, et al.
HIV Medicine
|
May 27, 2010
The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up
H Carsenti-Dellamonica, H Saïdi, M Ticchioni, et al.
HIV Medicine
|
April 27, 2017
Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study
P Gantner, L Cuzin, C Allavena, et al.
HIV Medicine
|
December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)
E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Pathologie-Biologie
|
December 1, 1991
[Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers]
H Etesse-Carsenti, R Garraffo, E Bernard, et al.
European Journal of Ophthalmology
|
January 19, 2008
Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteers
F Chiambaretta, R Garraffo, P P Elena, et al.
HIV Clinical Trials
|
December 26, 2002
Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir
S Chaillou, J Durant, R Garraffo, et al.
Alimentary Pharmacology & Therapeutics
|
June 15, 2018
Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort
A Provoost, M Dramé, L Cotte, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 31, 2005
Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance
Bernard Masquelier, Edwige Pereira, Gilles Peytavin, et al.
Fundamental & Clinical Pharmacology
|
February 24, 2001
Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients
F X Caroli-Bosc, A Iliadis, L Salmon, et al.
HIV Medicine
|
May 27, 2010
The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up
H Carsenti-Dellamonica, H Saïdi, M Ticchioni, et al.
HIV Medicine
|
April 27, 2017
Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study
P Gantner, L Cuzin, C Allavena, et al.
HIV Medicine
|
December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)
E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Page
of 7